T1	Participants 384 404	postmenopausal women
T2	Participants 491 667	222 postmenopausal women 45 years and older without cardiovascular disease and with low-density lipoprotein (LDL) cholesterol levels of 3.37 mmol/L or greater (> or = 130 mg/dL
T3	Participants 1092 1121	women randomized to estradiol
T4	Participants 1705 1725	postmenopausal women
T5	Participants 1805 1834	women randomized to estradiol
T6	Participants 1236 1351	fasting glucose, insulin, and hemoglobin A1C were lowered and insulin sensitivity increased with estradiol therapy,
